These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 18772098)

  • 21. Misoprostol preferable to ethacridine lactate for abortions at 13-20 weeks of pregnancy: Cuban experience.
    Boza AV; de León RG; Castillo LS; Mariño DR; Mitchell EM
    Reprod Health Matters; 2008 May; 16(31 Suppl):189-95. PubMed ID: 18772100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical management of early pregnancy failure: how to treat and what to expect.
    Dempsey A; Davis A
    Semin Reprod Med; 2008 Sep; 26(5):401-10. PubMed ID: 18825608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The choice of second trimester abortion method: evolution, evidence and ethics.
    Grimes DA
    Reprod Health Matters; 2008 May; 16(31 Suppl):183-8. PubMed ID: 18772099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol.
    Bagga R; Chaudhary N; Kalra J
    Int J Gynaecol Obstet; 2004 Oct; 87(1):42-3. PubMed ID: 15464778
    [No Abstract]   [Full Text] [Related]  

  • 26. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
    Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
    Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
    Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
    Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D
    Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol.
    Castleman LD; Oanh KT; Hyman AG; Thuy le T; Blumenthal PD
    Contraception; 2006 Sep; 74(3):272-6. PubMed ID: 16904423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine perforation as a rare complication of attempted pregnancy termination with misoprostol: a case report.
    Lialios G; Kallitsaris A; Mademtzis J; Messinis IE
    J Reprod Med; 2006 Jul; 51(7):599-600. PubMed ID: 16913556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City.
    Hu D; Grossman D; Levin C; Blanchard K; Goldie SJ
    BJOG; 2009 May; 116(6):768-79. PubMed ID: 19432565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mifepristone in second-trimester medical abortion: a randomized controlled trial.
    Kapp N; Borgatta L; Stubblefield P; Vragovic O; Moreno N
    Obstet Gynecol; 2007 Dec; 110(6):1304-10. PubMed ID: 18055725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical abortion.
    Bardin CW; Robbins A; O'Connor BM; Spitz I
    Curr Ther Endocrinol Metab; 1997; 6():305-11. PubMed ID: 9174759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
    Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
    Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
    Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.